✨ Education and Health Notices




2768 NEW ZEALAND GAZETTE No. 127

Change of Class of Flaxmere Intermediate

Dated at Wellington this 6th day of August 1992.

Pursuant to section 153 (1) (b) of the Education Act 1989 (as inserted by section 14 of the Education Amendment Act 1989), I hereby declare that Flaxmere Intermediate will be a composite school (F1–7) on the 1st day of January 1992 and cease to be an intermediate school on that day.

LOCKWOOD SMITH Ph.D., Minister of Education.

go7420


Health

Medicines Act 1981

Consent to the Distribution of a New Medicine

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of a new medicine set out in the Schedule hereto:

Schedule

Name and Strength Form Name and Address of Manufacturer Proprietary Name (if any)
Amorolfine 5% as the hydrochloride Nail lacquer Laboratoires Sauter SA, Vernier, Switzerland Loceryl

Dated this 25th day of April 1992.

Note: This replaces the consent gazetted 30 April 1992.

CHRISTOPHER LOVELACE, Director-General of Health, pursuant to delegation given by the Minister of Health on the 5th day of June 1991.

go7426


Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Name and Strength Form Name and Address of Manufacturer Proprietary Name (if any)
Oxerutins 250 mg Capsules Zyma Pharmaceuticals, Nyon, Switzerland Paroven
Atenolol 50 mg/12.5 mg chlorthalidone Tablets Gerard Laboratories, Dublin, Ireland Lo-Ten C
Atenolol 50 mg/25 mg chlorthalidone
Methotrexate 50 mg in 2 ml, 1000 mg in 10 ml, 500 mg in 20 ml Solution for injection Delta West Pty Limited, Bentley, Western Australia Methotrexate injection
Morphine sulphate 10 mg/ml Solution for injection (amp) Delta West Pty Limited, Bentley, Western Australia Morphine Sulphate injection
Cefodizime 250 mg, 500 mg, 1000 mg, 2000 mg Powder for reconstitution for injection Hoechst AG, Frankfurt/Main 80, Germany Timecef
Meningococcal vaccine groups A and C 50 mcg/dose (0.5 ml) purified polysaccharide each group Vaccine for reconstitution for injection (vial) SmithKline Beecham Biologicals S.A., Rixensart, Belgium Mencevax AC
Meningococcal vaccine groups A, C, W135 and Y 50 mcg/dose (0.5 ml) purified polysaccharide each group Vaccine for reconstitution for injection (vial) SmithKline Beecham Biologicals S.A., Rixensart, Belgium Mencevax ACWY

Dated this 31st day of July 1992.

CHRISTOPHER LOVELACE, Director-General of Health, pursuant to delegation given by the Minister of Health on the 5th day of June 1991.

go7425



Next Page →

PDF embedding disabled (Crown copyright)

View this page online at:


VUW Te Waharoa PDF NZ Gazette 1992, No 127


NZLII PDF NZ Gazette 1992, No 127





✨ LLM interpretation of page content

πŸŽ“ Change of Class of Flaxmere Intermediate

πŸŽ“ Education, Culture & Science
6 August 1992
Education, School Classification, Composite School, Flaxmere Intermediate
  • LOCKWOOD SMITH Ph.D., Minister of Education

πŸ₯ Consent to the Distribution of a New Medicine

πŸ₯ Health & Social Welfare
25 April 1992
Medicines Act, New Medicine, Amorolfine, Loceryl, Nail Lacquer
  • CHRISTOPHER LOVELACE, Director-General of Health

πŸ₯ Consent to the Distribution of New Medicines

πŸ₯ Health & Social Welfare
31 July 1992
Medicines Act, New Medicines, Oxerutins, Atenolol, Methotrexate, Morphine Sulphate, Cefodizime, Meningococcal Vaccine
  • CHRISTOPHER LOVELACE, Director-General of Health